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 The peripherin/RDS gene encodes a glycoprotein which
is confined to the outer segment disk of both rod and cone
photoreceptor cells [1,2]. The normal product of this gene,
peripherin, interacts in vivo with rod outer segment membrane
protein 1 (ROM1) in rods and plays an important structural
role in photoreceptor outer segments [3]. Over 70 mutations
in the peripherin/RDS gene have been reported in autosomal
dominant retinitis pigmentosa (ADRP) and autosomal domi-
nant macular dystrophy (adMD) [4-9], including a digenic trait
with the ROM1 gene [10]. Phenotypic variation has been ob-
served with different mutations in this gene, with an extreme
case of variable phenotypes within a family having a single
mutation showing retinitis pigmentosa (RP) and macular dys-
trophy (MD) [11,12]. In our previous screening for mutations
in the peripherin/RDS gene and in other RP and MD related
genes in index cases of autosomal dominant retinopathies and
simplex cases of RP, we found a lower contribution (1.3%) of
mutations in peripherin/RDS to ADRP [13] in a Spanish popu-
lation as compared to other screened populations. However,
we found a relatively high association (23%) of mutations in
this gene in families with autosomal dominant macular dys-
trophies. As reported in other populations, variability in macu-
lar dystrophy phenotype is also observed in this Spanish popu-
lation. We report the different macular dystrophy phenotypes
associated with mutations in the peripherin/RDS gene found
in a Spanish population and compare these phenotypes with
the associated mutations reported in other populations.
METHODS
 A cohort of 61 unrelated patients with various types of auto-
somal dominant macular dystrophies, aged between 26 and
75 years, participated in this study. Patients were recruited
from Fundación Jiménez Díaz (Madrid, Spain), Hospital de la
Santa Creu i Sant Pau (Barcelona, Spain) and Hospital de
Terrassa (Barcelona). A control group of 137 non-affected in-
dividuals was tested. Informed consent was obtained from all
subjects who participated in the study and the research ad-
hered to the tenets of the Declaration of Helsinki.
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Purpose: Mutations in the peripherin/retinal degeneration slow (RDS) gene are a known cause of various types of central
retinal dystrophies. The purpose of this study was to determine the prevalence of mutations in the peripherin/RDS gene in
Spanish patients with different types of autosomal dominant macular dystrophy.
Methods: Ophthalmic and electrophysiological examination was performed in patients from 61 unrelated autosomal
dominant macular dystrophy (adMD) Spanish families. Screening for mutations in the peripherin/RDS gene by denatur-
ing gradient gel electrophoresis (DGGE) and direct genomic sequencing was performed in index patients and extended to
the family when positive.
Results: We report four novel mutations in peripherin/RDS and a relatively high frequency (23%) of mutations in this
gene in families with adMD. Thirteen different mutations were found in fifteen adMD families. Three novel missense,
four nonsense and a cis-acting splicing mutation IVS2+2T>C, were found in a Spanish population while five more mis-
sense mutations were also reported in other populations. The Arg142Trp and Arg172Trp mutations, present in several
populations, were both detected in two independent Spanish families. All the missense mutations produce an amino acid
substitution in the second intradiscal loop of the peripherin, while the nonsense mutations presumably generate a trun-
cated protein.
Conclusions: A high frequency (23%) of mutations in the peripherin/RDS gene was found in a cohort of 61 unrelated
patients with various types of autosomal dominant central retinal dystrophies as compared with a low prevalence (1.3%)
of mutations in this gene causing retinitis pigmentosa in a Spanish population. Different macular dystrophy phenotypes
according to the mutations in peripherin/RDS are shown. However, a limited phenotype variation was observed for these
mutations within the family.
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1031Ophthalmologic and electrophysiological studies:  All in-
dividuals quoted above received a complete ophthalmic ex-
amination, which consisted of best corrected visual acuity with
Snellen optotypes, color vision with Farnsworth 32 hue test,
computerized perimetry (recorded on the Octopus 500) and
biomicroscopy and fundus examination after pupillary dila-
tion. Electroretinograms (ERG) and electrooculograms (EOG)
were performed according to the standard testing protocols
proposed by ISCEV [14].
Polymerase chain reaction: Genomic DNA was prepared
from peripheral blood lymphocytes using QIAmp DNA Blood
Mini Kit (Qiagen, Valencia, CA;). Flanking intronic and cod-
ing regions of exons 1 and 2 of the peripherin/RDS gene were
amplified using the primers shown in Table 1. One PCR primer
in each pair included a 40-base GC-rich segment (“GC-clamp”)
attached to its 5' end to facilitate detection of mutations by
denaturing gradient gel electrophoresis (DGGE). PCR reac-
tions were performed in a 50 ml volume of buffer (20 mM
Tris-HCl, pH 8.55, 16 mM (NH)2SO4, 1.5 mM MgCl2 150
mg/ml BSA, and 10% DMSO) containing 50-200 ng of hu-
man genomic DNA, 25 pmol of each primer, 10 nmol of each
deoxyribonucleoside triphosphate, and 1.5 units of Taq poly-
merase (Ecotaq, Barcelona, Spain). Incubation was performed
for 40 cycles consisting of 30 s at 94 °C, 30 s at 60 °C (for
exons 1A and 1B), 63 °C (for exon 2) or 54 °C (for exon 3),
and 30 s at 72 °C. This was followed by 5 min at 94 °C and 5
min at 72 °C. Electrophoresis of 8 ml of final PCR reaction
volume was performed on 1.5% agarose gel to test the ampli-
fication reaction.
Mutation detection:  PCR-amplified fragments contain-
ing the flanking intronic and coding sequences of exons 1 and
2 of the peripherin/RDS gene were analyzed. Exon 1 was di-
vided into two PCR fragments, 1A and 1B. Screening for
mutations was carried out by DGGE [15,16]. Electrophoretic
conditions (running temperature and denaturing gradient of
formamide/urea concentration range for each different PCR
product) are shown in Table 1. The PCR-amplified DNA frag-
ment containing exon 3 of peripherin/RDS was sequenced
directly because it is difficult to analyze by DGGE. When
DGGE variants were observed, the corresponding PCR frag-
ment was sequenced. For DNA sequencing, PCR products were
purified using Qiaquick Gel Extraction Purification Kit
(Qiagen). DNA sequencing was carried out with the same prim-
ers used for amplification with the OpenGene automated DNA
sequencing system from Visible Genetics and Thermo
Sequenase Cy5.5 Dye Terminator Cycle Sequencing Kit
(Amersham Pharmacia Biotech, Barcelona, Spain). Prediction
of the pathogenesis of the missense mutations was performed
using PolyPhen (Polymorphism phenotyping) program from
the Harvard University.
RESULTS
 Out of a total of 61 families studied, we found 13 different
mutations in peripherin/RDS in 15 families with adMD (Table
2). These mutations were absent in 137 controls used in
peripherin/RDS mutation screening. Co-segregation of the
mutation was performed in each family and a complete pen-
etrance was observed in all of them.
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TABLE 1. PRIMERS AND CONDITIONS USED FOR MUTATION DETECTION
                                          Annealing    Amplicon
                                         temperature     size
Primer         Sequence* (5'-3')             (°C)        (bp)     DGGE gradient
-------   ----------------------------   -----------   --------   --------------
Exon 1A
          F: (GC)-GGAAGCAACCCGGACTACAC       60          379         40-70%
          R: TAGCCAGGTACGGCTTCAGC
Exon 1B
          F: (GC)-ATTGCATGGAAGCCCTG          60          379         40-70%
          R: TCTGACCCCAGGACTGGAAG
Exon 2
          F: (GC)-AAGCCCATCTCCAGCTGT         63          353         45-75%
          R: CTTACCCTCTACCCCCAGCTG
Exon 3
          F: AGATTGCCTCTAAATCTCCT            54           294           -
          R: GGAGTGCACTATTTCTCAGT
Within the table, (GC) represents: 5'- CCG CCG CGC CCG CGC
CCG GCC CGC CGC CCC CGC CCG-3'. DGGE means denaturing
gradient gel electrophoresis. In DGGE gradient column, 100% dena-
turant equals to 7M urea and 40% (v/v) formamide.
TABLE 2. MUTATIONS IN THE PERIPHERIN/RDS GENE FOUND IN NISH PATIENTS WITH AUTOSOMAL DOMINANT MACULAR DYSTROPHY
             cDNA change
  Exon       (NM_000322)     Protein change     PSIC score difference   Phenotype     Reference
--------   ---------------   ----------------   ---------------------   ---------   -------------
1B         658 TAC>CAC       Tyr141His          2.148                   AVDM         [27]
1B         661 CGG>TGG       Arg142 Trp         2.118                   CACD        [27,28]
1B         678 del T         Gly148AlafsX152    -                       CACD        [29]
1B         751 CGG>TGG       Arg172Trp          2.606                   CACD        [4,21-25]
2          821 CGA>CTA       Arg195Leu          2.745                   PMD         [30]
2          846_862 del       Tyr204Pro fsX211   -                       PMD         [29]
2          860 GGC>GAC       Gly208Asp          1.843                   PMD         [29,31]
2          875 TGC>TTT       Cys213Phe          3.665                   AVMD        Present study
2          878 TGC>TAC       Cys214Tyr          3.665                   PMD         [27]
2          895 CGG>TGG       Arg220Trp          2.970                   BPD         [21]
2          948_959 del       Asp237_Thr240del   -                       BPD         Present study
2          975-978 dupGGTG   Arg248Gly fsX301   -                       PMD         Present study
Intron 2   IVS2+2 T>C        ----               -                       PMD         Present study
The following abbreviations were used: adult vitelliform macular dystrophy (AVMD); butterfly-shaped pattern dystrophy (BPD), central
areolar choroidal dystrophy (CACD), and pattern macular dystrophy (PMD). Position-specific independent counts (PSIC) score calculates the
difference between first and second amino acid variant.
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Figure 1. Pedigrees of novel reported Spanish families with mutation in the peripherin/RDS gene.  Solid, open, and scored symbols indicate
affected, unaffected and deceased individuals, respectively; arrows indicate probands. Bottom numbered symbols in pedigree correspond to
individuals whose DNA has been analyzed by DGGE and sequencing- In chromatogram of direct genomic sequencing of mutation, arrows
indicate position of mutation. AVMD indicates adult viteliform macular dystrophy; BPD indicates butterfly-shaped pattern dystrophy; CACD
indicates central areolar choroidal dystrophy; PMD indicates pattern macular dystrophy.
1033
Eight previously unreported families, are shown in Fig-
ure 1. Two of these mutations, Arg142Trp and Arg172Trp,
were detected in two unrelated Spanish families. Seven muta-
tions found in the peripherin/RDS gene are missense muta-
tions, and three, Tyr141His, Arg142Trp, and Cys213Phe, have
only been reported in a Spanish population, while the
Arg195Leu, Cys214Tyr, and Arg220Trp mutations have also
been found in other populations. Of the nonsense mutations
found, two are deletions (678delT and 846_862del), and one
is a 4 bp GGTG duplication. Additionally, IVS2+2T>C, a
mutation located in the intron 2 flanking splicing region, was
found. To predict the possible impact of this mutation in splic-
ing, we used Splice site prediction by neural network. This
program predicted a donor site in the exon/intron boundary
(GT) of intron 2, with a score of 0.98. We used a cutoff 0.40
for donor or acceptor sites. When mutation IVS2+2T>C oc-
curs, no donor site is predicted in exon/intron boundary of
intron 2, suggesting that this mutation probably abolishes the
canonical splice site.
The nonsense and splicing mutations identified are only
reported in a Spanish population. These nonsense mutations
presumably generate truncated proteins.
Ophthalmic examination and clinical studies of patients
were performed according to previously established protocols.
Different phenotypes, including central areolar choroidal dys-
trophy (CACD), adult vitelliform macular dystrophy (AVMD),
and pattern macular dystrophy (PMD; Figure 2) were found
for these peripherin/RDS mutations. Table 3 summarizes the
clinical features of the families.©2007 Molecular Vision Molecular Vision 2007; 13:1031-7 <http://www.molvis.org/molvis/v13/a112/>
Figure 2. Funduscopic pictures of
the different patterns observed in
Spanish families with autosomal-
dominant macular dystrophy fami-
lies of a Spanish population.  A:
Central areolar choroidal dystrophy
(CACD) caused by mutation
Arg142Trp in index patient (male,
39 years old) of family adMD-25.
B: Pattern macular dystrophy
(PMD) present in index patient
(male, 33 years old) of family
adMD-48, carrier of mutation
Arg195Leu. C: Adult vitelliform
macular dystrophy caused by mu-
tation Cys213Phe in patient II.4
(male, 34 years) of family adMD-
136.
1034DISCUSSION
 Peripherin/RDS is an integral membrane protein essential to
outer segment disk morphogenesis of rod and cone photore-
ceptor outer segments in the retina [1-3,17-19]. Mutations in
the peripherin/RDS gene cause a large variety of autosomal
dominant retinal degenerations, ranging from RP to MD [4].
In a Spanish population of nearly 200 index cases with
ADRP, we detected a lower frequency (1.3%) of mutations in
peripherin/RDS than in other reported populations [13]. How-
ever, we observed a relatively high frequency (23%) of muta-
tions in peripherin/RDS among autosomal dominant Spanish
families with central retinal dystrophies (adMD), slightly
©2007 Molecular Vision Molecular Vision 2007; 13:1031-7 <http://www.molvis.org/molvis/v13/a112/>
TABLE 3. SUMMARY OF CLINICAL ASPECTS IN MUTATED FAMILIES
                    Onset     Age at
                     of       visual
                    vision    acuity   Central
    Mutation        loss      <1/10     VF        Photo
    (family)       (years)   (years)   loss      /Metam                  Macula                             ERG
----------------   -------   -------   -------   ------   ----------------------------------------   --------------------
Tyr141His          40        ---       +          +/-     Yellowish lesions at macullae.             decrease amplitude
(DM-24)                                                   Atrophy and destructuration of RPE.        “b” wave in rods,
                                                          AVMD                                        mixed and cones
Arg142Trp          35        50        +                  Subretinian yellowish spots at macullae.
(DM-25)                                                   RPE destructuration  and atrophy. CACD
Arg142Trp          37        55        +                  CACD                                       decrease “b” wave
(DM-115)                                                                                             in cones
Gly148Ala fsX152   40-45     50        +          -/-     Subretinian yellowish round lesions.       decrease “b” wave
(DM-3)                                                    RPE destructuration and atrophy. CACD      in rods, mixed
                                                                                                     and cones
Arg172Trp          40        60        +          +/+     Irregular pigmentation.                    Normal
(DM-15b)                                                  Demarcated atrophy of central retina.
                                                          CACD.
Arg172Trp          35-55     60-75     +          +/+     Demarcated atrophy of central retina.      Normal
(DM-16b)                                                  CACD.
Arg195Leu          14        26        ++                 Yellow deposits. Destructuration of RPE.   Not Performed
(DM-48)                                                    PMD.
Tyr204ProfsX211    50-70     55-75     +/-        +/+     Yellow deposits. Destructuration of RPE.   Not Performed
(DM-2)                                                    PMD.
Gly208Asp          36                  +          -/+     RPE atrophy  Flecks in macula. PMD.        Photopic: Normal
(B-263)                                                                                              Scotopic: Normal
Cys213Phe          34        34        +          +       AVMD                                       Normal RE decrease
(DM-136)                                                                                             “b” wave in cones
                                                                                                     LE
Cys214Tyr          35                  -          -/+     Starred aspect and destructuration of      Not Performed
(DM-13)                                                   RPE. PMD.
Arg220Trp          45                  +         Total     BPD                                       Photopic: Normal
(B-197)                                          central                                             Scotopic: Normal
                                                 visual
                                                 loss
Asp237_Thr240del   43                  -          +/+     BPD                                        Photopic: Normal
(B-271)                                                                                              Scotopic: Diminished
Arg248GlyfsX301    36                             -/+     Macula RPE alteration. PMD.                Photopic: Normal
(B-206)                                                                                              Scotopic: Normal
IVS2+2T>C         48 years             +          -/-     Central RPE atrophy. PMD.
AVMD indicates adult viteliform macular dystrophy; BPD indicates butterfly-shaped pattern dystrophy; CACD indicates central areolar
choroidal dystrophy, ERG indicates electroretinogram, LE indicates left eye, Metam indicates metamorphosia, N.A indicates not available,
Photo indicates photophobia, RE indicates right eye, V.F indicates visual field.
1035higher than that seen in other studies of adMD (18% of AVMD)
[20], and 7.3% of adMD in a British population [21].
Specific mutations in the peripherin/RDS gene may lead
to a wide inter- and intra-familial variability of phenotypes.
Although phenotype-genotype correlations have been sug-
gested depending on the location and type of mutations in
peripherin/RDS, a general rule cannot yet be established. How-
ever, a common phenotype of adMD has been described for
the most reported mutation, Arg172Trp, found in British,
Swiss, Swedish, Japanese, and Spanish populations [21-25].
But for the Cys214Tyr mutation, an MD phenotype has been
found in one of the Spanish families, while a mutation in the
same codon but causing a different amino acid residue substi-
tution, Cys214Ser, has been previously reported to be associ-
ated with an RP phenotype [26].
Most pathogenic mutations associated with human reti-
nal dystrophies alter a conserved extracellular/intradiscal do-
main, EC2, in the protein. Studies carried out by Goldberg et
al. [17] showed that changes within the EC2 domain may cause
either gross protein misfolding as well as a reduction in pro-
tein sedimentation coefficient, while mutations outside the EC2
domain do not seem to affect the protein folding and tetrameric
subunit assembly formed by peripherin/RDS and ROM1 pro-
tein. All mutations described here lie in EC2, or they produce
a predictable truncated protein within this domain. This find-
ing, together with the experimental results observed with
peripherin/RDS mutants, suggest a pathogenic mechanism
associated with misfolding or reduction of tetrameric subunit
assembly in cones that leads to macular degeneration in the
retina. Research carried out with animal models by Kedzierski
et al [18] studying rds and rom1 transgenic/knockout mice
found that photoreceptor degeneration in peripherin/RDS-
mediated RP appears to be caused by a simple deficiency of
rds and rom1. Thus, below a critical threshold for the com-
bined abundance of rds and rom1, the extent of outer segment
(OS) disorganization results in clinically significant photore-
ceptor degeneration. In this case, a general haploinsufficiency
mechanism could be hypothesized, that isspecially associated
with mutations producing null alleles. However, in our stud-
ies, the severity and phenotype of the two frameshift changes
reported (857del17bp, causing PMD, and 689delT, causing
CACD) are not well correlated with the type of mutation and
they produced different types of retinal affectation. Although
a haploinsufficiency mechanism mediated by peripherin/RDS
mutations could not be discarded, more plausible is a patho-
genic mechanism that involves a negative dominant effect that
could be modulated by other genetic elements that can con-
tribute to the observed heterogeneity of retinal disease pheno-
types.
The present study confirms that phenotype-genotype cor-
relation is only feasible for a restricted number of peripherin/
RDS mutations, including the most frequently observed
Arg172Trp. More descriptions are needed to provide more
clues to understanding the underlying mechanisms of photo-
receptor degeneration as a consequence of peripherin/RDS
mutations
In conclusion, we report four novel mutations and ob-
served a relatively high incidence of mutations in the
peripherin/RDS gene in a population of Spanish families with
autosomal dominant macular dystrophies with variable phe-
notypes. However, a relatively homogeneous intra-familial
expression of the disease was noted.
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